SPONSOR
Alpha Tau Medical LTD.
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Malignant TumorNon-metastatic Prostate CancerLocally Recurrent Prostate CancerRecurrent Lung CancerLung Cancer
Alpha Tau Medical LTD. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Malignant Tumor, Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer, Recurrent Lung Cancer.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Alpha Tau Medical LTD.
How many clinical trials has Alpha Tau Medical LTD. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Alpha Tau Medical LTD., of which 3 are actively recruiting participants. These trials cover conditions including Malignant Tumor, Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Alpha Tau Medical LTD. research focus on?
Alpha Tau Medical LTD. clinical trials span Malignant Tumor, Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer, Recurrent Lung Cancer, Lung Cancer. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Alpha Tau Medical LTD. clinical trial?
To participate in a Alpha Tau Medical LTD. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Alpha Tau Medical LTD. trials with current recruitment status updated daily.
Clinical Trials by Alpha Tau Medical LTD.
NCT05781555
Recruiting
Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
Malignant Tumor
NCT06202248
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.
Non-metastatic Prostate Cancer
NCT05632913
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer
Recurrent Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology